| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.76 | 0.001 | 0.76 | GABA B receptor antagonist | 0.163 0.004 CID_3078139 | ||
| 0.352 | 0.004 | 0.352 | GABA receptor antagonist | 0.232 0.005 CID_3078139 | ||
| 0.314 | 0.013 | 0.314 | Cyclooxygenase 1 inhibitor | 0.187 0.04 CID_3078139 | ||
| 0.283 | 0.004 | 0.283 | GABA A receptor antagonist | 0.051 0.04 CID_3078139 | ||
| 0.267 | 0.01 | 0.267 | MAP kinase 12 inhibitor | 0.174 0.031 CID_3078139 | ||
| 0.259 | 0.002 | 0.262 | CXC chemokine 1 receptor antagonist | 0.262 0.002 CID_3078139 | CID_3078139 | |
| 0.234 | 0.03 | 0.247 | Cyclooxygenase inhibitor | 0.247 0.027 CID_3078139 | CID_3078139 | |
| 0.226 | 0.029 | 0.226 | Interleukin 6 antagonist | |||
| 0.19 | 0.01 | 0.214 | Potassium channel activator | 0.214 0.007 CID_3078139 | CID_3078139 | |
| 0.241 | 0.065 | 0.241 | Neuropeptide Y2 antagonist | |||
| 0.177 | 0.009 | 0.188 | Cyclin B3 inhibitor | 0.188 0.007 CID_3078139 | CID_3078139 | |
| 0.189 | 0.031 | 0.189 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.188 | 0.031 | 0.188 | Abl kinase inhibitor | |||
| 0.158 | 0.016 | 0.158 | MAP kinase 11 inhibitor | 0.08 0.048 CID_3078139 | ||
| 0.157 | 0.033 | 0.157 | MAP kinase 13 inhibitor | |||
| 0.126 | 0.011 | 0.126 | Human rhinovirus A protease inhibitor | |||
| 0.126 | 0.015 | 0.141 | CXC chemokine receptor antagonist | 0.141 0.012 CID_3078139 | CID_3078139 | |
| 0.121 | 0.012 | 0.143 | Elastase 1 inhibitor | 0.143 0.007 CID_3078139 | CID_3078139 | |
| 0.186 | 0.083 | 0.186 | Non-steroidal antiinflammatory agent | 0.173 0.093 CID_3078139 | ||
| 0.189 | 0.096 | 0.189 | EphB2 antagonist | |||
| 0.096 | 0.005 | 0.096 | Dihydroorotate oxidase inhibitor | 0.084 0.009 CID_3078139 | ||
| 0.125 | 0.045 | 0.13 | Chemokine receptor antagonist | 0.13 0.042 CID_3078139 | CID_3078139 | |
| 0.107 | 0.032 | 0.107 | MAP kinase 14 inhibitor | 0.065 0.059 CID_3078139 | ||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | 0.07 0.032 CID_3078139 | ||
| 0.073 | 0.019 | 0.073 | Cyclin B2 inhibitor | 0.061 0.03 CID_3078139 | ||
| 0.078 | 0.027 | 0.078 | Exportin-1 inhibitor | |||
| 0.11 | 0.07 | 0.11 | CDK3/cyclin E inhibitor | |||
| 0.064 | 0.027 | 0.064 | Cyclin B inhibitor | 0.054 0.04 CID_3078139 | ||
| 0.095 | 0.06 | 0.125 | Potassium channel (Ca-activated) activator | 0.125 0.038 CID_3078139 | CID_3078139 | |
| 0.059 | 0.027 | 0.059 | H+/K+-transporting ATPase inhibitor | |||
| 0.064 | 0.041 | 0.076 | Cannabinoid CB1 receptor antagonist | 0.076 0.03 CID_3078139 | CID_3078139 | |
| 0.051 | 0.033 | 0.054 | Potassium channel (Inward rectifier) activator | 0.054 0.028 CID_3078139 | CID_3078139 | |
| 0.049 | 0.031 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.027 CID_3078139 | CID_3078139 | |
| 0.11 | 0.092 | 0.248 | Cyclooxygenase 2 inhibitor | 0.248 0.02 CID_3078139 | CID_3078139 | |
| 0.064 | 0.052 | 0.073 | Potassium channel large-conductance Ca-activated activator | 0.073 0.041 CID_3078139 | CID_3078139 | |
| 0.023 | 0.014 | 0.027 | Elastase 2A inhibitor | 0.027 0.011 CID_3078139 | CID_3078139 | |
| 0.023 | 0.014 | 0.027 | Elastase 2 inhibitor | 0.027 0.011 CID_3078139 | CID_3078139 | |
| 0.056 | 0.048 | 0.069 | Ca(v)3.2 blocker | 0.069 0.024 CID_3078139 | CID_3078139 | |
| 0.064 | 0.081 | 0.072 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.072 0.065 CID_3078139 | CID_3078139 | |
| 0.018 | 0.036 | 0.026 | CXC chemokine 2 receptor antagonist | 0.026 0.018 CID_3078139 | CID_3078139 | |
| 0.097 | 0.118 | 0.161 | Sodium channel blocker | 0.161 0.051 CID_3078139 | CID_3078139 | |
| 0.05 | 0.08 | 0.074 | Cannabinoid receptor antagonist | 0.074 0.045 CID_3078139 | CID_3078139 | |
| 0.047 | 0.087 | 0.076 | Nav1.7 sodium channel blocker | 0.076 0.038 CID_3078139 | CID_3078139 | |
| 0.039 | 0.142 | 0.219 | Bcl2 antagonist | 0.219 0.004 CID_3078139 | CID_3078139 | |
| 0.069 | 0.174 | 0.133 | Sodium channel (voltage-gated) blocker | 0.133 0.07 CID_3078139 | CID_3078139 | |
| 0.011 | 0.117 | 0.049 | Kinesin antagonist | 0.049 0.017 CID_3078139 | CID_3078139 | |
| 0.011 | 0.117 | 0.049 | Kinesin-like protein 1 inhibitor | 0.049 0.017 CID_3078139 | CID_3078139 | |
| 0.035 | 0.147 | 0.08 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.018 CID_3078139 | CID_3078139 | |
| 0.011 | 0.129 | 0.042 | Liver X receptor antagonist | 0.042 0.013 CID_3078139 | CID_3078139 | |
| 0.009 | 0.134 | 0.125 | Janus tyrosine kinase 1 inhibitor | 0.125 0.014 CID_3078139 | CID_3078139 | |
| 0.04 | 0.18 | 0.08 | Kallikrein 7 inhibitor | 0.08 0.014 CID_3078139 | CID_3078139 | |
| 0.008 | 0.17 | 0.031 | Liver X receptor beta antagonist | 0.031 0.018 CID_3078139 | CID_3078139 | |
| 0.037 | 0.202 | 0.113 | Bcl-xL inhibitor | 0.113 0.005 CID_3078139 | CID_3078139 | |
| 0.067 | 0.261 | 0.11 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.094 CID_3078139 | CID_3078139 | |
| 0.021 | 0.221 | 0.113 | Vanilloid 1 antagonist | 0.113 0.022 CID_3078139 | CID_3078139 | |
| 0.025 | 0.251 | 0.088 | MAP kinase kinase 10 inhibitor | 0.088 0.024 CID_3078139 | CID_3078139 | |
| 0.019 | 0.252 | 0.078 | Janus tyrosine kinase 2 inhibitor | 0.078 0.049 CID_3078139 | CID_3078139 | |
| 0.011 | 0.248 | 0.065 | Liver X receptor agonist | 0.065 0.014 CID_3078139 | CID_3078139 | |
| 0.006 | 0.287 | 0.03 | Liver X receptor beta agonist | 0.03 0.028 CID_3078139 | CID_3078139 | |
| 0.07 | 0.482 | 0.349 | Immunomodulator | 0.349 0.06 CID_3078139 | CID_3078139 | |
| 0.049 | 0.531 | 0.398 | Antiobesity | 0.398 0.066 CID_3078139 | CID_3078139 | |
| 0.015 | 0.823 | 0.257 | Cyclophilin D inhibitor | 0.257 0.205 CID_3078139 | CID_3078139 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |